API Suppliers
US DMFs Filed
CEP/COS Certifications
JDMFs Filed
Other Certificates
Other Suppliers
USA (Orange Book)
Europe
Canada
Australia
South Africa
Uploaded Dossiers
U.S. Medicaid
Annual Reports
0
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=213371
https://www.prnewswire.com/news-releases/poseida-therapeutics-provides-updates-and-financial-results-for-the-second-quarter-of-2022-301604618.html
https://recalls-rappels.canada.ca/en/alert-recall/taro-zoledronic-acid-affected-lots-may-contain-particulate-matter
https://www.europeanpharmaceuticalreview.com/news/132430/common-osteoporosis-treatments-could-reduce-incidence-of-covid-19/
https://www.pharmacompass.com/pdf/news/health-canada-issues-recall-of-taro-pharmaceuticalss-zoledronic-acid-1586233601.pdf
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=209578
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=208513
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=209578
https://www.washingtonpost.com/business/economy/investigation-of-generic-cartel-expands-to-300-drugs/2018/12/09/fb900e80-f708-11e8-863c-9e2f864d47e7_story.html?noredirect=on&utm_term=.1556274f9387
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=204344
https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-october-3-2018-1538550050.pdf
https://www.moneycontrol.com/news/business/dr-reddys-laboratories-recalls-around-70000-vials-of-zoledronic-acid-injection-from-us-3009141.html
https://www.api.polpharma.com/regulatory-news/available-cep-for-api-zoledronic-acid
https://www.fiercepharma.com/pharma/novartis-redelegates-malaysia-head-to-lead-scandal-hit-korean-branch-report
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=205749
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=207341
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=209125
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=205254
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=210174
http://www.prnewswire.com/news-releases/mylan-launches-generic-reclast-injection-300467691.html
http://www.dddmag.com/news/2017/04/amgen-submits-applications-us-europe-expand-current-indication-xgeva
http://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=203841
http://www.prnewswire.com/news-releases/grunenthal-has-acquired-us-based-thar-pharmaceuticals-inc-to-expand-its-development-portfolio-of-treatment-options-for-crps-complex-regional-pain-syndrome-a-serious-disabling-orphan-disease-601529065.html
http://www.prnewswire.com/news-releases/amgen-announces-positive-top-line-results-from-xgeva-denosumab-phase-3-trial-for-delay-of-bone-complications-in-multiple-myeloma-patients-300348779.html
https://www.pharmacompass.com/pdf/news/gland-pharma-ltd-receives-fda-nod-for-zoledronic-acid-1472292812.pdf
http://indianexpress.com/article/india/india-others/12-cancer-drugs-may-come-under-price-control/
http://www.ema.europa.eu/ema/index.jsp?curl=pages/news_and_events/news/2015/03/news_detail_002294.jsp&mid=WC0b01ac058004d5c1
http://www.ema.europa.eu/ema/index.jsp?curl=pages/news_and_events/news/2015/03/news_detail_002287.jsp&mid=WC0b01ac058004d5c1